Side Effects of New Immuno-Modulators (abstract)

Update item information
Identifier 20170406_nanos_nosideeffects1_03-abstract
Title Side Effects of New Immuno-Modulators (abstract)
Creator Ore-ofe Oluwaseun Adesina, MD
Subject Rheumatologic drugs, Biologics, Demyelination, Visual loss
Description Medications used in the management of rheumatologic disorders include therapeutic agents with varying mechanisms of action. The older well known drugs include glucocorticoids, non-steroidal anti-inflammatory drugs and the antimetabolites and cytotoxic medications such as cyclophosphamide, mycophenolate mofetil, methotrexate and azathioprine (disease modifying anti-rheumatic drugs - DMARDs). Of particular interest, however, are the drugs known as biologics. These drugs are not derived from compounds with predictable chemical structures; rather they are complex molecules or mixtures of molecules that are produced by the cells of living microorganisms, plants or animals, often using recombinant DNA.
Relation is Part of NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis
Contributor Primary Ore-ofe Oluwaseun Adesina, MD
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2017
Format application/pdf
Source 2017 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6k68c64
Setname ehsl_novel_nam
Date Created 2017-08-30
Date Modified 2022-05-24
ID 1273220
Reference URL
Back to Search Results